Risk of Meningioma Among Users of High Doses of Cyproterone Acetate Compared With the General Population: Evidence From a Population-Based Cohort Study
May 2011
in “
British Journal of Clinical Pharmacology
”
Studysummary This study found that high doses of cyproterone acetate were associated with an increased risk of meningioma, especially with exposure longer than one year.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on europepmc.org →